Sign In
Buy CDXS
$1.40
-0.0800 (-5.41%)
At Close: Jul 31, 2026
Codexis (CDXS) Gets a Buy Rating from H.C. Wainwright - Markets
10:21am, Wednesday, 24'th Jun 2020
H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on Codexis (CDXS – Research Report) today and set a price
Avid Bioservices Names Nicholas Green as President and Chief Executive Officer | MarketScreener
12:06pm, Tuesday, 23'rd Jun 2020Codexis and Molecular Assemblies Partner to Transform the Field of DNA Synthesis
11:00am, Tuesday, 23'rd Jun 2020
Codexis, Inc. (CDXS), a leading protein engineering company and developer of high-performance enzymes, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announce a par
A New Way Of Making DNA Is About To Revolutionize The Biotech Industry
12:00am, Tuesday, 23'rd Jun 2020
Has the next biotech unicorn just been minted? Two California firms are focused on a radical new way of writing DNA to create everything from COVID-19 antibodies to high-density data storage.
Hedge Funds Are Selling Codexis, Inc. (CDXS)
07:06pm, Monday, 22'nd Jun 2020
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Ev
Codexis Announces the Election of New Directors at its Annual Meeting of Stockholders
08:05pm, Tuesday, 16'th Jun 2020
Codexis, Inc. (CDXS), a leading protein engineering company and developer of high-performance enzymes, announces the election of new independent directors, Alison Moore, Ph.D. and Stephen Dilly, MBBS,
Global Biocatalysis & Biocatalyst Market Trends, Forecast and Competitive Analysis to 2024 - ResearchAndMarkets.com
12:00am, Friday, 12'th Jun 2020
The
Edited Transcript of CDXS earnings conference call or presentation 7-May-20 8:30pm GMT
03:19pm, Tuesday, 02'nd Jun 2020
Q1 2020 Codexis Inc Earnings Call
Codexis and Alphazyme Partner to Offer Novel Enzymes to Life Science and Diagnostic Markets
08:06pm, Monday, 01'st Jun 2020Codexis and Alphazyme Partner to Offer Novel Enzymes to Life Science and Diagnostic Markets
08:05pm, Monday, 01'st Jun 2020
Codexis, Inc. (CDXS), a leading protein engineering company and developer of high-performance enzymes, and Alphazyme LLC, an emerging leader in the development and manufacture of nucleic acid metaboli
Bleichroeder LP Buys Altice USA Inc, Brunswick Corp, Haymaker Acquisition Corp II, Sells Arqule ...
12:00am, Thursday, 28'th May 2020Codexis to Participate in Two Virtual Investment Conferences
11:00am, Wednesday, 27'th May 2020
REDWOOD CITY, Calif., May 27, 2020 -- Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that management will participate in two virtual investment.
Codexis to Participate in Two Virtual Investment Conferences
12:00am, Wednesday, 27'th May 2020Should Codexis Investors Prepare for Slower Growth?
11:31pm, Friday, 22'nd May 2020
The company's largest source of revenue will be affected by the pandemic, but there appears to be a silver lining.
